Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences
Alzheimer’s disease (AD) is the most common type of dementia, mainly encompassing cognitive decline in subjects aged ≥65 years. Further, AD is characterized by selective synaptic and neuronal degeneration, vascular dysfunction, and two histopathological features: extracellular amyloid plaques compos...
Saved in:
Main Authors: | Gloria Ortiz-Guerrero, Diana Amador-Muñoz, Carlos Alberto Calderón-Ospina, Daniel López-Fuentes, Mauricio Orlando Nava Mesa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2018/5257285 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deprescribing proton pump inhibitors
by: Kim Jun Kevin Teh, et al.
Published: (2023-08-01) -
Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01) -
Proton Pump Inhibitors: How Appropriate?
by: Daniel C Sadowski
Published: (2000-01-01) -
Proton pump inhibitor leaflets: Is there information on deprescribing?
by: Marcus Vinícius Lopes Campos, et al.
Published: (2025-01-01) -
Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01)